hcpcs_code
stringlengths
5
5
hcpcs_description
stringlengths
10
256
n_providers
int64
1
498k
total_services
int64
408k
102M
total_medicare_payment
int64
11.8k
8.43B
avg_submitted_charge
int64
0
9.01k
91320
Sarscv2 vac 30mcg trs-suc im
36,800
4,506,697
663,520,364
163
82043
Urine microalbumin (protein) level
11,597
4,427,155
24,993,863
58
87086
Bacterial colony count, urine
4,506
4,406,190
34,813,358
51
99284
Emergency department visit with moderate level of medical decision making
65,448
4,389,227
374,843,174
795
97116
Therapy procedure for walking training, each 15 minutes
12,009
4,365,251
74,403,934
55
A0436
Rotary wing air mileage, per statute mile
348
4,291,202
131,395,606
357
J2357
Injection, omalizumab, 5 mg
617
3,851,801
113,422,267
84
90837
Psychotherapy, 1 hour
15,804
3,792,555
372,578,448
211
J7318
Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg
1,475
3,779,716
19,209,975
31
J1437
Injection, ferric derisomaltose, 10 mg
969
3,751,157
59,095,356
66
Q9966
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml
1,582
3,744,455
1,076,615
5
J7195
Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified
2
3,739,916
5,269,023
3
J0885
Injection, epoetin alfa, (for non-esrd use), 1000 units
806
3,729,400
23,493,119
29
88341
Special stained specimen slides to examine tissue, each additional procedure
10,448
3,714,400
119,025,755
147
A0427
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency)
6,857
3,690,907
1,522,290,381
1,634
97535
Training for self-care or home management, each 15 minutes
17,873
3,689,997
72,561,916
63
Q5125
Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
145
3,670,982
1,390,117
2
91322
Sarscov2 vac 50 mcg/0.5ml im
31,346
3,668,923
564,768,020
171
J7320
Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg
347
3,633,116
15,360,495
22
74177
Ct scan of abdomen and pelvis with contrast
23,893
3,593,132
287,212,665
613
67028
Injection of drug into eye
4,305
3,573,623
331,533,616
583
99349
Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes
14,815
3,553,733
294,272,869
224
J2356
Injection, tezepelumab-ekko, 1 mg
206
3,539,998
49,939,375
42
83540
Iron level
8,692
3,526,157
22,309,606
33
90653
Influenza vaccine, inactivated
43,932
3,476,036
282,893,756
98
11102
Biopsy of related skin growth, first growth
19,666
3,452,445
206,752,898
225
83735
Magnesium level
7,154
3,435,068
22,513,816
38
92250
Photography of the retina
25,483
3,413,264
86,790,642
119
99231
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
44,310
3,401,229
125,911,678
118
82728
Ferritin (blood protein) level
8,894
3,396,801
45,282,197
79
98940
Chiropractic manipulative treatment, 1-2 spinal regions
11,909
3,370,055
62,816,386
49
85027
Complete blood cell count (red cells, white blood cell, platelets), automated test
7,224
3,287,573
20,807,456
32
J7187
Injection, von willebrand factor complex (humate-p), per iu vwf:rco
1
3,232,019
3,484,523
2
84153
Psa (prostate specific antigen) measurement, total
8,103
3,225,143
58,001,445
103
92012
Established patient problem focused exam of visual system
15,822
3,111,523
198,920,759
168
17110
Destruction of skin growth, 1-14 growths
20,550
3,076,352
226,537,539
243
J7325
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg
1,653
3,066,514
21,151,093
33
J7336
Capsaicin 8% patch, per square centimeter
82
3,063,583
7,935,176
8
J7329
Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg
766
3,040,002
17,037,259
36
99439
Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
10,926
2,958,539
106,566,352
97
87481
Detection test for candida species (yeast), amplified probe technique
1,217
2,935,874
99,973,379
60
A0428
Ambulance service, basic life support, non-emergency transport, (bls)
2,683
2,897,867
599,919,046
1,128
83550
Iron binding capacity
6,736
2,879,215
24,627,731
45
J1569
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
593
2,848,101
101,026,285
128
77080
Dxa bone density measurement of hip, pelvis, spine
16,549
2,823,698
60,142,604
156
A0435
Fixed wing air mileage, per statute mile
89
2,819,231
32,904,745
139
J3304
Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
1,076
2,762,340
37,625,348
48
77014
Ct guidance for insertion of radiation therapy fields
4,401
2,745,231
153,845,243
304
87186
Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution
2,406
2,718,641
23,016,992
55
92133
Imaging of optic nerve
25,384
2,709,619
64,643,492
111
J9025
Injection, azacitidine, 1 mg
198
2,695,927
793,386
9
J0178
Injection, aflibercept, 1 mg
3,155
2,690,616
1,756,326,820
1,717
97150
Therapy procedure in a group setting
10,254
2,656,691
27,997,116
51
92083
Exam of visual field with extended testing
25,834
2,652,036
114,310,947
150
J0872
Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
18
2,637,395
476,948
1
84550
Uric acid level, blood
5,995
2,619,033
11,578,630
31
A0429
Ambulance service, basic life support, emergency transport (bls-emergency)
7,742
2,598,660
914,248,770
1,252
73030
X-ray of shoulder, minimum of 2 views
34,654
2,588,028
41,533,486
90
82746
Folic acid level, serum
5,438
2,560,679
36,849,296
86
J2469
Injection, palonosetron hcl, 25 mcg
2,612
2,556,985
1,813,652
55
99497
Advance care planning, first 30 minutes
29,529
2,539,170
156,798,979
185
85610
Blood test, clotting time
7,719
2,529,787
10,605,081
29
J0588
Injection, incobotulinumtoxin a, 1 unit
256
2,512,769
10,139,941
12
G0444
Annual depression screening, 5 to 15 minutes
27,976
2,511,578
44,699,861
41
99457
Management using the results of remote vital sign monitoring per calendar month, first 20 minutes
6,982
2,500,830
93,814,831
114
86003
Measurement of antibody (ige) to allergic substance, crude allergen extract, each
284
2,483,466
12,683,511
31
71250
Ct scan of chest without contrast
21,933
2,464,435
121,548,831
418
99205
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
67,958
2,462,628
377,969,743
562
J2781
Injection, pegcetacoplan, intravitreal, 1 mg
857
2,452,956
286,096,570
299
73502
X-ray of hip, 2-3 views
33,149
2,430,495
46,696,753
100
88342
Special stained specimen slides to examine tissue, initial procedure
11,517
2,417,798
111,797,225
193
J2919
Injection, methylprednisolone sodium succinate, 5 mg
2,341
2,389,093
530,545
2
73630
X-ray of foot, minimum of 3 views
30,446
2,379,415
42,146,811
82
86140
Measurement c-reactive protein for detection of infection or inflammation
3,894
2,334,614
11,833,382
56
J0665
Injection, bupivicaine, not otherwise specified, 0.5 mg
765
2,264,496
21,867
2
J2785
Injection, regadenoson, 0.1 mg
6,356
2,216,463
11,810,171
141
87088
Bacterial urine culture
1,895
2,200,443
17,430,880
31
95117
Professional service for multiple injections of allergen
4,073
2,140,086
17,904,613
36
Q9965
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml
284
2,137,868
2,315,475
3
82784
Gammaglobulin (immune system protein) measurement
1,626
2,134,006
19,408,426
58
73562
X-ray of knee, 3 views
26,591
2,129,460
42,250,673
103
G0471
Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)
108
2,124,275
22,429,905
19
85652
Red blood cell sedimentation rate, to detect inflammation, automated
3,237
2,124,132
5,617,568
30
99310
Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes
13,634
2,124,063
225,517,156
293
90834
Psychotherapy, 45 minutes
10,253
2,079,420
140,257,392
177
J0702
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
8,965
2,075,988
10,777,534
20
99458
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes
4,522
2,066,989
63,275,800
88
99454
Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days
6,419
2,027,677
74,901,155
130
88185
Flow cytometry technique for dna or cell analysis, each additional marker
624
2,005,386
38,818,547
110
93296
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days
5,002
1,969,899
30,756,134
93
J1568
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
447
1,950,771
70,990,965
182
81002
Urinalysis, manual test
28,951
1,948,017
6,609,748
15
J9030
Bcg live intravesical instillation, 1 mg
860
1,933,786
4,268,412
8
74176
Ct scan of abdomen and pelvis without contrast
22,065
1,923,949
130,710,123
556
87077
Bacterial culture for aerobic isolates
1,961
1,916,230
15,156,144
33
51798
Ultrasound measurement of bladder capacity after voiding
9,700
1,904,122
15,808,282
71
80307
Testing for presence of drug, by chemistry analyzers
4,731
1,887,956
113,859,278
211
74018
X-ray of abdomen, 1 view
21,785
1,886,352
15,847,798
54
93294
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days
7,475
1,877,558
38,294,438
106
Q5101
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram
80
1,869,848
470,130
2